argenx SE (STU:1AE)
€ 348.6 18.5 (5.6%) Market Cap: 20.50 Bil Enterprise Value: 17.60 Bil PE Ratio: 0 PB Ratio: 5.43 GF Score: 69/100

Q2 2021 argenx SE Earnings Call Transcript

Jul 29, 2021 / 12:30PM GMT
Release Date Price: €252 (+0.80%)
Operator

Good morning, everyone. My name is Jamie, and I will be your conference operator today. At this time, I would like to welcome everyone to the conference. (Operator Instructions)

At this time, I'd like to introduce Beth DelGiacco, Vice President of Corporate Communications and Investor Relations. Ma'am, you may begin.

Beth DelGiacco
argenx SE - VP of IR

Thank you, operator. A press release was issued earlier today with our first half 2021 financial results and second quarter business update. This can be found on our website along with the presentation for today's webcast. I also encourage you all to visit our R&D Day microsite, also on the Investor page of our website, to watch a replay of the presentations and engage with the additional resources we've provided as part of the event.

Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical developments, regulatory time lines, the potential success of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot